Enanta Pharmaceuticals
ENTA
ENTA
144 hedge funds and large institutions have $805M invested in Enanta Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 64 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 146 → 144 (-2)
7% less capital invested
Capital invested by funds: $869M → $805M (-$63.9M)
33% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 64
Holders
144
Holding in Top 10
1
Calls
$4.12M
Puts
$440K
Top Buyers
| 1 | +$28.8M | |
| 2 | +$8M | |
| 3 | +$7.89M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.32M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.77M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$5.85M | |
| 3 | -$5.12M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.45M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.2M |